Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Expands By 69.0%

Posted by Amy Steele on Nov 15th, 2024

Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 607,700 shares, an increase of 69.0% from the October 15th total of 359,500 shares. Based on an average daily volume of 270,200 shares, the days-to-cover ratio is currently 2.2 days.

Ascentage Pharma Group International Price Performance

ASPHF stock remained flat at $6.45 during mid-day trading on Friday. The company’s fifty day moving average is $4.19 and its 200-day moving average is $3.20. Ascentage Pharma Group International has a 1 year low of $6.45 and a 1 year high of $6.45.

About Ascentage Pharma Group International

(Get Free Report)

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.